Moderna (MRNA) Treasury Shares (2016 - 2025)

Moderna (MRNA) has 10 years of Treasury Shares data on file, last reported at $11.2 million in Q4 2025.

• Treasury Shares for Q4 2025 came in at $11.2 million, up 42.49% year-over-year; the trailing twelve-month figure through Dec 2025 was $11.2 million (up 42.49% YoY), and the FY2025 annual result was $11.2 million, up 42.49% from the prior year.
• Treasury Shares improved to $11.2 million in Q4 2025 per MRNA's latest filing, from $7.9 million in the prior quarter.
• Over five years, Treasury Shares peaked at $23.0 million in Q4 2022 and troughed at $2.2 million in Q3 2021.
• A 5-year average of $7.4 million and a median of $7.4 million in 2022 frame the typical range for Treasury Shares.
• The sharpest annual moves came in 2022 and 2023: Treasury Shares jumped 666.67% in 2022, then tumbled 65.22% in 2023.
• A 5-year view of Treasury Shares shows it stood at $3.0 million in 2021, then jumped by 666.67% to $23.0 million in 2022, then plunged by 65.22% to $8.0 million in 2023, then slipped by 1.75% to $7.9 million in 2024, then jumped by 42.49% to $11.2 million in 2025.
• Business Quant data shows MRNA's Treasury Shares at $11.2 million in Q4 2025, $7.9 million in Q4 2024, and $8.0 million in Q4 2023.